{"prediction": {"id": "5407d9b5-a8a6-5dc9-8ba9-d6c70198f5b1", "work_id": "7340ab6d-41fb-5632-9783-37959e51bf21", "study_id": "31ef18e7-3d61-5c06-9203-eb5ad2eecda7", "kind": "Model scenario comparison", "pages": [2], "version": "Version of record", "source_work_id": "7340ab6d-41fb-5632-9783-37959e51bf21", "title": "Virtual population pharmacokinetic using physiologically based pharmacokinetic model for evaluating bioequivalence of oral lacidipine formulations in dogs.", "doi": "10.1016/j.ajps.2016.03.003", "pdf_sha256": "5834d7f8715d8b5493e1083a49d68624dd5cf7a84ae9d0c8103a363b94ad39ba", "physical_page_count": 7}, "fields": {"endpoint": {"value": "relative_bioavailability_panel__bioequivalence_interval_threshold_attainment", "source_basis": "verified_profile", "pages": [2]}, "family": {"value": "pharmacokinetic_exposure", "source_basis": "verified_profile", "pages": [2]}, "measured_variable": {"value": "relative_bioavailability_panel", "source_basis": "verified_profile", "pages": [2]}, "measurement_role": {"value": "exposure_outcome", "source_basis": "original_pdf_review", "pages": [2]}, "metric": {"value": "bioequivalence_interval_threshold_attainment", "source_basis": "verified_profile", "pages": [2]}, "model": {"value": "mechanistic_or_numerical", "source_basis": "verified_profile", "pages": [1, 2]}, "reference_type": {"value": "observed_experimental_reference", "source_basis": "verified_profile", "pages": [2]}, "role": {"value": "simulated_output", "source_basis": "verified_profile", "pages": [2]}, "scenario": {"value": "virtual_sample_size_comparison", "source_basis": "verified_profile", "pages": [2]}}, "endpoints": [{"term": "area_under_curve", "label": "Area under the curve (AUC)"}, {"term": "pharmacokinetics", "label": "Pharmacokinetics and drug exposure"}], "validations": [], "model_resources": {"total": 0, "page": 1, "limit": 50, "rows": [], "review_status": "indexed_source"}}